In a diverse cohort of virologically suppressed women with HIV, long-acting cabotegravir and rilpivirine (CAB+RPV LA) maintained high rates of viral suppression with low virologic failure over a median...
Researchers evaluated the safety and efficacy of dolutegravir plus lamivudine in treatment-naive individuals with HIV without baseline resistance testing.
A multi-center study finds kidney transplantation from HIV-positive donors to HIV-positive recipients is as safe and effective as using kidneys from HIV-negative donors, offering new insights into expanding...
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...
In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...
Researchers tested the impact of four different remotely delivered interventions and observed promising effects on several key health outcomes in patients over the age of 50 living with HIV.
In a cohort study, researchers observed a significant decrease in incident reinfection among patients with Hepatitis C who received increased follow-up after achieving sustained virologic response.
A team of researchers sought to determine the incidence of inappropriate diagnosis among patients hospitalized and treated for community-acquired pneumonia.
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
